Global Biotechnology Instrumentation Market
As the global economy mends, the 2021 growth of Biotechnology Instrumentation will have significa ... Read More
Global Bio-pharma Market Growth 2024-2031
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bio-pharma Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Bio-pharma by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Bio-pharma by Country/Region, 2017, 2022 & 2028
2.2 Bio-pharma Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Recombinant Proteins
2.2.3 Granulocyte-Colony Stimulating Factor (G-CSF)
2.2.4 Interferons
2.2.5 Recombinant Human Insulin
2.2.6 Erythropoietin
2.2.7 Vaccines
2.2.8 Growth Hormones
2.2.9 Purified Proteins
2.2.10 Others
2.3 Bio-pharma Sales by Type
2.3.1 Global Bio-pharma Sales Market Share by Type (2017-2022)
2.3.2 Global Bio-pharma Revenue and Market Share by Type (2017-2022)
2.3.3 Global Bio-pharma Sale Price by Type (2017-2022)
2.4 Bio-pharma Segment by Application
2.4.1 Metabolic Disorders
2.4.2 Oncology
2.4.3 Neurological Disorders
2.4.4 Cardiovascular Diseases
2.4.5 Inflammatory and Infectious Diseases
2.4.6 Others
2.5 Bio-pharma Sales by Application
2.5.1 Global Bio-pharma Sale Market Share by Application (2017-2022)
2.5.2 Global Bio-pharma Revenue and Market Share by Application (2017-2022)
2.5.3 Global Bio-pharma Sale Price by Application (2017-2022)
3 Global Bio-pharma by Company
3.1 Global Bio-pharma Breakdown Data by Company
3.1.1 Global Bio-pharma Annual Sales by Company (2020-2022)
3.1.2 Global Bio-pharma Sales Market Share by Company (2020-2022)
3.2 Global Bio-pharma Annual Revenue by Company (2020-2022)
3.2.1 Global Bio-pharma Revenue by Company (2020-2022)
3.2.2 Global Bio-pharma Revenue Market Share by Company (2020-2022)
3.3 Global Bio-pharma Sale Price by Company
3.4 Key Manufacturers Bio-pharma Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bio-pharma Product Location Distribution
3.4.2 Players Bio-pharma Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bio-pharma by Geographic Region
4.1 World Historic Bio-pharma Market Size by Geographic Region (2017-2022)
4.1.1 Global Bio-pharma Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Bio-pharma Annual Revenue by Geographic Region
4.2 World Historic Bio-pharma Market Size by Country/Region (2017-2022)
4.2.1 Global Bio-pharma Annual Sales by Country/Region (2017-2022)
4.2.2 Global Bio-pharma Annual Revenue by Country/Region
4.3 Americas Bio-pharma Sales Growth
4.4 APAC Bio-pharma Sales Growth
4.5 Europe Bio-pharma Sales Growth
4.6 Middle East & Africa Bio-pharma Sales Growth
5 Americas
5.1 Americas Bio-pharma Sales by Country
5.1.1 Americas Bio-pharma Sales by Country (2017-2022)
5.1.2 Americas Bio-pharma Revenue by Country (2017-2022)
5.2 Americas Bio-pharma Sales by Type
5.3 Americas Bio-pharma Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio-pharma Sales by Region
6.1.1 APAC Bio-pharma Sales by Region (2017-2022)
6.1.2 APAC Bio-pharma Revenue by Region (2017-2022)
6.2 APAC Bio-pharma Sales by Type
6.3 APAC Bio-pharma Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bio-pharma by Country
7.1.1 Europe Bio-pharma Sales by Country (2017-2022)
7.1.2 Europe Bio-pharma Revenue by Country (2017-2022)
7.2 Europe Bio-pharma Sales by Type
7.3 Europe Bio-pharma Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bio-pharma by Country
8.1.1 Middle East & Africa Bio-pharma Sales by Country (2017-2022)
8.1.2 Middle East & Africa Bio-pharma Revenue by Country (2017-2022)
8.2 Middle East & Africa Bio-pharma Sales by Type
8.3 Middle East & Africa Bio-pharma Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bio-pharma
10.3 Manufacturing Process Analysis of Bio-pharma
10.4 Industry Chain Structure of Bio-pharma
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bio-pharma Distributors
11.3 Bio-pharma Customer
12 World Forecast Review for Bio-pharma by Geographic Region
12.1 Global Bio-pharma Market Size Forecast by Region
12.1.1 Global Bio-pharma Forecast by Region (2023-2028)
12.1.2 Global Bio-pharma Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bio-pharma Forecast by Type
12.7 Global Bio-pharma Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Bio-pharma Product Offered
13.1.3 Pfizer Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 F. Hoffmann-La Roche AG
13.2.1 F. Hoffmann-La Roche AG Company Information
13.2.2 F. Hoffmann-La Roche AG Bio-pharma Product Offered
13.2.3 F. Hoffmann-La Roche AG Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 F. Hoffmann-La Roche AG Main Business Overview
13.2.5 F. Hoffmann-La Roche AG Latest Developments
13.3 Johnson & Johnson Services
13.3.1 Johnson & Johnson Services Company Information
13.3.2 Johnson & Johnson Services Bio-pharma Product Offered
13.3.3 Johnson & Johnson Services Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Johnson & Johnson Services Main Business Overview
13.3.5 Johnson & Johnson Services Latest Developments
13.4 Sanofi, Amgen
13.4.1 Sanofi, Amgen Company Information
13.4.2 Sanofi, Amgen Bio-pharma Product Offered
13.4.3 Sanofi, Amgen Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sanofi, Amgen Main Business Overview
13.4.5 Sanofi, Amgen Latest Developments
13.5 AbbVie
13.5.1 AbbVie Company Information
13.5.2 AbbVie Bio-pharma Product Offered
13.5.3 AbbVie Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AbbVie Main Business Overview
13.5.5 AbbVie Latest Developments
13.6 Merck & Co., Inc
13.6.1 Merck & Co., Inc Company Information
13.6.2 Merck & Co., Inc Bio-pharma Product Offered
13.6.3 Merck & Co., Inc Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Merck & Co., Inc Main Business Overview
13.6.5 Merck & Co., Inc Latest Developments
13.7 Biogen Idec
13.7.1 Biogen Idec Company Information
13.7.2 Biogen Idec Bio-pharma Product Offered
13.7.3 Biogen Idec Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Biogen Idec Main Business Overview
13.7.5 Biogen Idec Latest Developments
13.8 Bayer AG
13.8.1 Bayer AG Company Information
13.8.2 Bayer AG Bio-pharma Product Offered
13.8.3 Bayer AG Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bayer AG Main Business Overview
13.8.5 Bayer AG Latest Developments
13.9 Eli Lilly and Company
13.9.1 Eli Lilly and Company Company Information
13.9.2 Eli Lilly and Company Bio-pharma Product Offered
13.9.3 Eli Lilly and Company Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Eli Lilly and Company Main Business Overview
13.9.5 Eli Lilly and Company Latest Developments
13.10 Novartis AG GlaxoSmithKline Plc
13.10.1 Novartis AG GlaxoSmithKline Plc Company Information
13.10.2 Novartis AG GlaxoSmithKline Plc Bio-pharma Product Offered
13.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis AG GlaxoSmithKline Plc Main Business Overview
13.10.5 Novartis AG GlaxoSmithKline Plc Latest Developments
13.11 Bristol-Myers Squibb Company
13.11.1 Bristol-Myers Squibb Company Company Information
13.11.2 Bristol-Myers Squibb Company Bio-pharma Product Offered
13.11.3 Bristol-Myers Squibb Company Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Bristol-Myers Squibb Company Main Business Overview
13.11.5 Bristol-Myers Squibb Company Latest Developments
13.12 AstraZeneca PLC
13.12.1 AstraZeneca PLC Company Information
13.12.2 AstraZeneca PLC Bio-pharma Product Offered
13.12.3 AstraZeneca PLC Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 AstraZeneca PLC Main Business Overview
13.12.5 AstraZeneca PLC Latest Developments
13.13 Abbott Laboratories
13.13.1 Abbott Laboratories Company Information
13.13.2 Abbott Laboratories Bio-pharma Product Offered
13.13.3 Abbott Laboratories Bio-pharma Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Abbott Laboratories Main Business Overview
13.13.5 Abbott Laboratories Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Bio-pharma Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Bio-pharma Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Recombinant Proteins
Table 5. Major Players of Granulocyte-Colony Stimulating Factor (G-CSF)
Table 6. Major Players of Interferons
Table 7. Major Players of Recombinant Human Insulin
Table 8. Major Players of Erythropoietin
Table 9. Major Players of Vaccines
Table 10. Major Players of Growth Hormones
Table 11. Major Players of Purified Proteins
Table 12. Major Players of Others
Table 13. Global Bio-pharma Sales by Type (2017-2022) & (K Pcs)
Table 14. Global Bio-pharma Sales Market Share by Type (2017-2022)
Table 15. Global Bio-pharma Revenue by Type (2017-2022) & ($ million)
Table 16. Global Bio-pharma Revenue Market Share by Type (2017-2022)
Table 17. Global Bio-pharma Sale Price by Type (2017-2022) & (USD/Pcs)
Table 18. Global Bio-pharma Sales by Application (2017-2022) & (K Pcs)
Table 19. Global Bio-pharma Sales Market Share by Application (2017-2022)
Table 20. Global Bio-pharma Revenue by Application (2017-2022)
Table 21. Global Bio-pharma Revenue Market Share by Application (2017-2022)
Table 22. Global Bio-pharma Sale Price by Application (2017-2022) & (USD/Pcs)
Table 23. Global Bio-pharma Sales by Company (2020-2022) & (K Pcs)
Table 24. Global Bio-pharma Sales Market Share by Company (2020-2022)
Table 25. Global Bio-pharma Revenue by Company (2020-2022) ($ Millions)
Table 26. Global Bio-pharma Revenue Market Share by Company (2020-2022)
Table 27. Global Bio-pharma Sale Price by Company (2020-2022) & (USD/Pcs)
Table 28. Key Manufacturers Bio-pharma Producing Area Distribution and Sales Area
Table 29. Players Bio-pharma Products Offered
Table 30. Bio-pharma Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Bio-pharma Sales by Geographic Region (2017-2022) & (K Pcs)
Table 34. Global Bio-pharma Sales Market Share Geographic Region (2017-2022)
Table 35. Global Bio-pharma Revenue by Geographic Region (2017-2022) & ($ millions)
Table 36. Global Bio-pharma Revenue Market Share by Geographic Region (2017-2022)
Table 37. Global Bio-pharma Sales by Country/Region (2017-2022) & (K Pcs)
Table 38. Global Bio-pharma Sales Market Share by Country/Region (2017-2022)
Table 39. Global Bio-pharma Revenue by Country/Region (2017-2022) & ($ millions)
Table 40. Global Bio-pharma Revenue Market Share by Country/Region (2017-2022)
Table 41. Americas Bio-pharma Sales by Country (2017-2022) & (K Pcs)
Table 42. Americas Bio-pharma Sales Market Share by Country (2017-2022)
Table 43. Americas Bio-pharma Revenue by Country (2017-2022) & ($ Millions)
Table 44. Americas Bio-pharma Revenue Market Share by Country (2017-2022)
Table 45. Americas Bio-pharma Sales by Type (2017-2022) & (K Pcs)
Table 46. Americas Bio-pharma Sales Market Share by Type (2017-2022)
Table 47. Americas Bio-pharma Sales by Application (2017-2022) & (K Pcs)
Table 48. Americas Bio-pharma Sales Market Share by Application (2017-2022)
Table 49. APAC Bio-pharma Sales by Region (2017-2022) & (K Pcs)
Table 50. APAC Bio-pharma Sales Market Share by Region (2017-2022)
Table 51. APAC Bio-pharma Revenue by Region (2017-2022) & ($ Millions)
Table 52. APAC Bio-pharma Revenue Market Share by Region (2017-2022)
Table 53. APAC Bio-pharma Sales by Type (2017-2022) & (K Pcs)
Table 54. APAC Bio-pharma Sales Market Share by Type (2017-2022)
Table 55. APAC Bio-pharma Sales by Application (2017-2022) & (K Pcs)
Table 56. APAC Bio-pharma Sales Market Share by Application (2017-2022)
Table 57. Europe Bio-pharma Sales by Country (2017-2022) & (K Pcs)
Table 58. Europe Bio-pharma Sales Market Share by Country (2017-2022)
Table 59. Europe Bio-pharma Revenue by Country (2017-2022) & ($ Millions)
Table 60. Europe Bio-pharma Revenue Market Share by Country (2017-2022)
Table 61. Europe Bio-pharma Sales by Type (2017-2022) & (K Pcs)
Table 62. Europe Bio-pharma Sales Market Share by Type (2017-2022)
Table 63. Europe Bio-pharma Sales by Application (2017-2022) & (K Pcs)
Table 64. Europe Bio-pharma Sales Market Share by Application (2017-2022)
Table 65. Middle East & Africa Bio-pharma Sales by Country (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Bio-pharma Sales Market Share by Country (2017-2022)
Table 67. Middle East & Africa Bio-pharma Revenue by Country (2017-2022) & ($ Millions)
Table 68. Middle East & Africa Bio-pharma Revenue Market Share by Country (2017-2022)
Table 69. Middle East & Africa Bio-pharma Sales by Type (2017-2022) & (K Pcs)
Table 70. Middle East & Africa Bio-pharma Sales Market Share by Type (2017-2022)
Table 71. Middle East & Africa Bio-pharma Sales by Application (2017-2022) & (K Pcs)
Table 72. Middle East & Africa Bio-pharma Sales Market Share by Application (2017-2022)
Table 73. Key Market Drivers & Growth Opportunities of Bio-pharma
Table 74. Key Market Challenges & Risks of Bio-pharma
Table 75. Key Industry Trends of Bio-pharma
Table 76. Bio-pharma Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Bio-pharma Distributors List
Table 79. Bio-pharma Customer List
Table 80. Global Bio-pharma Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. Global Bio-pharma Sales Market Forecast by Region
Table 82. Global Bio-pharma Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Global Bio-pharma Revenue Market Share Forecast by Region (2023-2028)
Table 84. Americas Bio-pharma Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Americas Bio-pharma Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. APAC Bio-pharma Sales Forecast by Region (2023-2028) & (K Pcs)
Table 87. APAC Bio-pharma Revenue Forecast by Region (2023-2028) & ($ millions)
Table 88. Europe Bio-pharma Sales Forecast by Country (2023-2028) & (K Pcs)
Table 89. Europe Bio-pharma Revenue Forecast by Country (2023-2028) & ($ millions)
Table 90. Middle East & Africa Bio-pharma Sales Forecast by Country (2023-2028) & (K Pcs)
Table 91. Middle East & Africa Bio-pharma Revenue Forecast by Country (2023-2028) & ($ millions)
Table 92. Global Bio-pharma Sales Forecast by Type (2023-2028) & (K Pcs)
Table 93. Global Bio-pharma Sales Market Share Forecast by Type (2023-2028)
Table 94. Global Bio-pharma Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 95. Global Bio-pharma Revenue Market Share Forecast by Type (2023-2028)
Table 96. Global Bio-pharma Sales Forecast by Application (2023-2028) & (K Pcs)
Table 97. Global Bio-pharma Sales Market Share Forecast by Application (2023-2028)
Table 98. Global Bio-pharma Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 99. Global Bio-pharma Revenue Market Share Forecast by Application (2023-2028)
Table 100. Pfizer Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors
Table 101. Pfizer Bio-pharma Product Offered
Table 102. Pfizer Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Pfizer Main Business
Table 104. Pfizer Latest Developments
Table 105. F. Hoffmann-La Roche AG Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors
Table 106. F. Hoffmann-La Roche AG Bio-pharma Product Offered
Table 107. F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. F. Hoffmann-La Roche AG Main Business
Table 109. F. Hoffmann-La Roche AG Latest Developments
Table 110. Johnson & Johnson Services Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors
Table 111. Johnson & Johnson Services Bio-pharma Product Offered
Table 112. Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Johnson & Johnson Services Main Business
Table 114. Johnson & Johnson Services Latest Developments
Table 115. Sanofi, Amgen Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors
Table 116. Sanofi, Amgen Bio-pharma Product Offered
Table 117. Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Sanofi, Amgen Main Business
Table 119. Sanofi, Amgen Latest Developments
Table 120. AbbVie Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors
Table 121. AbbVie Bio-pharma Product Offered
Table 122. AbbVie Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. AbbVie Main Business
Table 124. AbbVie Latest Developments
Table 125. Merck & Co., Inc Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors
Table 126. Merck & Co., Inc Bio-pharma Product Offered
Table 127. Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Merck & Co., Inc Main Business
Table 129. Merck & Co., Inc Latest Developments
Table 130. Biogen Idec Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors
Table 131. Biogen Idec Bio-pharma Product Offered
Table 132. Biogen Idec Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Biogen Idec Main Business
Table 134. Biogen Idec Latest Developments
Table 135. Bayer AG Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors
Table 136. Bayer AG Bio-pharma Product Offered
Table 137. Bayer AG Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Bayer AG Main Business
Table 139. Bayer AG Latest Developments
Table 140. Eli Lilly and Company Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors
Table 141. Eli Lilly and Company Bio-pharma Product Offered
Table 142. Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. Eli Lilly and Company Main Business
Table 144. Eli Lilly and Company Latest Developments
Table 145. Novartis AG GlaxoSmithKline Plc Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors
Table 146. Novartis AG GlaxoSmithKline Plc Bio-pharma Product Offered
Table 147. Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 148. Novartis AG GlaxoSmithKline Plc Main Business
Table 149. Novartis AG GlaxoSmithKline Plc Latest Developments
Table 150. Bristol-Myers Squibb Company Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors
Table 151. Bristol-Myers Squibb Company Bio-pharma Product Offered
Table 152. Bristol-Myers Squibb Company Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 153. Bristol-Myers Squibb Company Main Business
Table 154. Bristol-Myers Squibb Company Latest Developments
Table 155. AstraZeneca PLC Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors
Table 156. AstraZeneca PLC Bio-pharma Product Offered
Table 157. AstraZeneca PLC Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 158. AstraZeneca PLC Main Business
Table 159. AstraZeneca PLC Latest Developments
Table 160. Abbott Laboratories Basic Information, Bio-pharma Manufacturing Base, Sales Area and Its Competitors
Table 161. Abbott Laboratories Bio-pharma Product Offered
Table 162. Abbott Laboratories Bio-pharma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 163. Abbott Laboratories Main Business
Table 164. Abbott Laboratories Latest Developments
List of Figures
Figure 1. Picture of Bio-pharma
Figure 2. Bio-pharma Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bio-pharma Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Bio-pharma Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Bio-pharma Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Monoclonal Antibodies
Figure 10. Product Picture of Recombinant Proteins
Figure 11. Product Picture of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure 12. Product Picture of Interferons
Figure 13. Product Picture of Recombinant Human Insulin
Figure 14. Product Picture of Erythropoietin
Figure 15. Product Picture of Vaccines
Figure 16. Product Picture of Growth Hormones
Figure 17. Product Picture of Purified Proteins
Figure 18. Product Picture of Others
Figure 19. Global Bio-pharma Sales Market Share by Type in 2021
Figure 20. Global Bio-pharma Revenue Market Share by Type (2017-2022)
Figure 21. Bio-pharma Consumed in Metabolic Disorders
Figure 22. Global Bio-pharma Market: Metabolic Disorders (2017-2022) & (K Pcs)
Figure 23. Bio-pharma Consumed in Oncology
Figure 24. Global Bio-pharma Market: Oncology (2017-2022) & (K Pcs)
Figure 25. Bio-pharma Consumed in Neurological Disorders
Figure 26. Global Bio-pharma Market: Neurological Disorders (2017-2022) & (K Pcs)
Figure 27. Bio-pharma Consumed in Cardiovascular Diseases
Figure 28. Global Bio-pharma Market: Cardiovascular Diseases (2017-2022) & (K Pcs)
Figure 29. Bio-pharma Consumed in Inflammatory and Infectious Diseases
Figure 30. Global Bio-pharma Market: Inflammatory and Infectious Diseases (2017-2022) & (K Pcs)
Figure 31. Bio-pharma Consumed in Others
Figure 32. Global Bio-pharma Market: Others (2017-2022) & (K Pcs)
Figure 33. Global Bio-pharma Sales Market Share by Application (2017-2022)
Figure 34. Global Bio-pharma Revenue Market Share by Application in 2021
Figure 35. Bio-pharma Revenue Market by Company in 2021 ($ Million)
Figure 36. Global Bio-pharma Revenue Market Share by Company in 2021
Figure 37. Global Bio-pharma Sales Market Share by Geographic Region (2017-2022)
Figure 38. Global Bio-pharma Revenue Market Share by Geographic Region in 2021
Figure 39. Global Bio-pharma Sales Market Share by Region (2017-2022)
Figure 40. Global Bio-pharma Revenue Market Share by Country/Region in 2021
Figure 41. Americas Bio-pharma Sales 2017-2022 (K Pcs)
Figure 42. Americas Bio-pharma Revenue 2017-2022 ($ Millions)
Figure 43. APAC Bio-pharma Sales 2017-2022 (K Pcs)
Figure 44. APAC Bio-pharma Revenue 2017-2022 ($ Millions)
Figure 45. Europe Bio-pharma Sales 2017-2022 (K Pcs)
Figure 46. Europe Bio-pharma Revenue 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Bio-pharma Sales 2017-2022 (K Pcs)
Figure 48. Middle East & Africa Bio-pharma Revenue 2017-2022 ($ Millions)
Figure 49. Americas Bio-pharma Sales Market Share by Country in 2021
Figure 50. Americas Bio-pharma Revenue Market Share by Country in 2021
Figure 51. United States Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 52. Canada Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 53. Mexico Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 54. Brazil Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 55. APAC Bio-pharma Sales Market Share by Region in 2021
Figure 56. APAC Bio-pharma Revenue Market Share by Regions in 2021
Figure 57. China Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 58. Japan Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Korea Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 60. Southeast Asia Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 61. India Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 62. Australia Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 63. Europe Bio-pharma Sales Market Share by Country in 2021
Figure 64. Europe Bio-pharma Revenue Market Share by Country in 2021
Figure 65. Germany Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 66. France Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 67. UK Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 68. Italy Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 69. Russia Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 70. Middle East & Africa Bio-pharma Sales Market Share by Country in 2021
Figure 71. Middle East & Africa Bio-pharma Revenue Market Share by Country in 2021
Figure 72. Egypt Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 73. South Africa Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 74. Israel Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 75. Turkey Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 76. GCC Country Bio-pharma Revenue Growth 2017-2022 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Bio-pharma in 2021
Figure 78. Manufacturing Process Analysis of Bio-pharma
Figure 79. Industry Chain Structure of Bio-pharma
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Please ask for List of Figures. Request Sample Report